Abstract
The report covers forecast and analysis for the active wound care market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the active wound care market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active wound care market on a global level.
In order to give the users of this report a comprehensive view on the active wound care market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type segment, wound type segment, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.
The study provides a decisive view of the active wound care market by segmenting the market based on product type, wound type, end user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on product type, the market is segmented into synthetic skin grafts, allograft, xenografts, amniotic tissue grafts, collagen dressings, and growth factors. On the basis of wound type, the market is segmented into surgical wounds, ulcers, and other wounds. The ulcers segment is further sub-segmented into pressure ulcers, diabetic foot ulcers, arterial ulcers, and venous ulcers. Based on end users, the market is segmented into in-patient facilities and out-patient facilities. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., the U.K., Germany, France, Italy, Spain, China, Japan, India, Brazil, and GCC Countries. This segmentation includes demand for active wound care market based on individual product type, wound type, and end users in all the regions and countries.
The report also includes detailed profiles of end players such as Smith and Nephew, Molnlycke Health Care AB, Integra Life Sciences Corporation, Baxter, Medtronic, ConvaTec Inc., Coloplast Corporation, Organogenesis Inc., KCI Licensing, Inc., Medline Industries, Inc., Avita Medical, Osiris Therapeutics, Inc., Cytori Therapeutics Inc., and Wright Medical Group N.V.
This report segments the global active wound care market as follows:
Global Active Wound Care Market: Product Type Segment Analysis
Synthetic Skin Grafts
Allograft
Xenografts
Amniotic Tissue Grafts
Collagen Dressings
Growth Factors
Global Active Wound Care Market: Wound Type Segment Analysis
Surgical Wounds
Ulcers
Pressure Ulcers
Diabetic Foot Ulcers
Arterial Ulcers
Venous Ulcers
Other Wounds
Global Active Wound Care Market: End-User Segment Analysis
In-Patient Facilities
Out-Patient Facilities
Global Active Wound Care Market: Regional Segment Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa